MG
JAZZ icon

Michael Gelband’s Jazz Pharmaceuticals JAZZ Stock Holding History

Michael Gelband’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.8M Sell
53,201
-125,578
-70% -$27.5M 0.08% 232
2026
Q1 		$33.8M Buy
178,779
+41,229
+30% +$7.21M 0.27% 48
2025
Q4 		$23.4M Buy
137,550
+116,542
+555% +$17.9M 0.18% 86
2025
Q3 		$2.77M Sell
21,008
-11,311
-35% -$1.36M 0.03% 619
2025
Q2 		$3.43M Sell
32,319
-80,245
-71% -$8.72M 0.03% 545
2025
Q1 		$14M Buy
+112,564
New +$14.7M 0.14% 148
2024
Q3 		– Sell
-35,432
Closed -$3.78M – 1840
2024
Q2 		$3.78M Buy
+35,432
New +$3.9M 0.03% 513
2023
Q2 		– Sell
-10,205
Closed -$1.49M – 2049
2023
Q1 		$1.49M Buy
+10,205
New +$1.51M 0.01% 1000
2022
Q4 		– Sell
-30,979
Closed -$4.13M – 1872
2022
Q3 		$4.13M Buy
+30,979
New +$4.71M 0.05% 472
2022
Q1 		– Sell
-12,360
Closed -$1.57M – 2423
2021
Q4 		$1.57M Buy
12,360
+6,853
+124% +$901K 0.02% 860
2021
Q3 		$717K Buy
+5,507
New +$832K 0.01% 1195
2021
Q2 		– Sell
-2,301
Closed -$378K – 2574
2021
Q1 		$378K Buy
+2,301
New +$379K 0.01% 1527
2020
Q1 		– Sell
-3,592
Closed -$536K – 1355
2019
Q4 		$536K Buy
3,592
+95
+3% +$12.9K 0.01% 821
2019
Q3 		$448K Sell
3,497
-713
-17% -$95.6K 0.02% 709
2019
Q2 		$600K Buy
+4,210
New +$566K 0.02% 397

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Michael Gelband's JAZZ Position: Q2 2026 in Review

Michael Gelband reduced its Jazz Pharmaceuticals (JAZZ) stake by 70% in Q2 2026, selling an estimated $27.5M and leaving 53,201 shares worth $12.8M. The position accounts for 0.08% of the portfolio, ranked #232.

Michael Gelband first reported a position in JAZZ in Q2 2019 and has held it in 15 quarters since. The position peaked at $33.8M in Q1 2026. 640 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Michael Gelband held 53,201 shares of Jazz Pharmaceuticals worth $12.8M as of Q2 2026.
  • Michael Gelband sold 125,578 Jazz Pharmaceuticals shares in Q2 2026, an estimated $27.5M.
  • Jazz Pharmaceuticals made up 0.08% of Michael Gelband's portfolio in Q2 2026, its #232 holding.
  • Michael Gelband first reported a position in Jazz Pharmaceuticals in Q2 2019 and has held it in 15 quarters since.
  • Michael Gelband's Jazz Pharmaceuticals position peaked at $33.8M in Q1 2026.
  • 640 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.